Oncofetal antigen multi-peptide immunotherapy

· Benovus Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oncofetal antigen multi-peptide immunotherapy, covering 2016-04-19 to 2016-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer [Phase 1]